Skip to content
Screener

Ranpak Holdings PACK Europe/Asia — Stock-based compensation expense

Similar metrics at other companies

FactSet Research Systems logo
FDSAsia Pacific — Stock-based compensation expense
$1.4M+20.9%
FactSet Research Systems logo
FDSAmericas — Stock-based compensation expense
$17.92M+32.8%
FactSet Research Systems logo
FDSEMEA — Stock-based compensation expense
$2.9M+22.8%
GHC
GHCEducation — Stock-based compensation expense
$475K+280%
Collegium Pharmaceutical, Inc. logo
COLLSegment — Stock-based compensation expense
$14.48M+33.9%
Domo, Inc. logo
DOMOSubscription — Stock-based compensation expense
$816K+21.8%

Other financials

Income statement

See full
Revenue$105.2M+14.0%
Gross profit$34.5M+19.4%
Operating income-$2.4M+75.3%
Net income-$7.9M-5.3%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$43.2M-12.2%
Total debt$429.7M-0.8%
Total equity$519.9M-3.5%
Total assets$1.1B-3.6%

Cash flow

See full
Operating cash flow$2.7M+175%
CapEx$2.7M+42.1%
Free cash flow$3.5M+333%

Valuation

See full
Market cap$445.94M+31.2%
Enterprise value$832.44M+15.0%
P/S1.1×+0.2×

Profitability

See full
Gross margin33.6%-2.0pp
Operating margin-3.1%
Net margin-9.1%-0.6pp
FCF margin6.1%-2.5pp

Returns & leverage

See full
Return on equity-7.2%+0.5pp
Debt / equity0.8×0.0×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Ranpak Holdings in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The source filing: Ranpak Holdings’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 9:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050839
Line itemThree Months Ended June 30, 2026 / North AmericaThree Months Ended June 30, 2026 / Europe/AsiaThree Months Ended June 30, 2026 / ConsolidatedSix Months Ended June 30, 2026 / North AmericaSix Months Ended June 30, 2026 / Europe/AsiaSix Months Ended June 30, 2026 / Consolidated
Cost of sales excluding depreciation and amortization30.533.058.663.4
Compensation expense(1)12.515.125.830.8
Professional fees2.01.04.02.0
Stock-based compensation0.90.32.10.4
Other operating expense, net0.70.21.0
Foreign currency (gain) loss(0.5)0.7(3.1)4.6
Other (income) expense, net(2)(4.9)5.0(9.9)10.0
Other segment items(3)(1.2)(3.0)(2.7)(5.6)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Ranpak Holdings's europe/asia — stock-based compensation expense?
Ranpak Holdings (PACK) reported europe/asia — stock-based compensation expense of $300K in Q2 2026.
How has Ranpak Holdings's europe/asia — stock-based compensation expense changed year-over-year?
Ranpak Holdings's europe/asia — stock-based compensation expense decreased by 40.0% year-over-year, from $500K to $300K.
What is the long-term trend for Ranpak Holdings's europe/asia — stock-based compensation expense?
Over 3 years (2022 to 2025), Ranpak Holdings's europe/asia — stock-based compensation expense has grown at a -28.4% compound annual growth rate (CAGR), from $4.9M to $1.8M.
What does europe/asia — stock-based compensation expense mean?
This metric represents the non-cash expense recognized for equity-based awards granted to employees within the Europe and Asia segment. It reflects the cost of aligning employee incentives with shareholder interests through stock options or restricted stock units. Investors monitor this to understand the impact of equity dilution and total compensation structures on segment profitability.

Ask your AI about Ranpak Holdings's europe/asia — stock-based compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude